WilsonCMertensMDMSBA

PubMed

• 3 citations
  Mode of Detection of Second Events in Routine Surveillance of Early Stage Breast Cancer Patients.
  Soe Min Tun, Sunitha Alluri, Vida Rastegar, Paul Visintainer, Wilson Mertens, Grace Makari-Judson> ;Clinical Breast Cancer. 2022 Oct 1
• 3 citations
  Insulin resistance and weight gain in women treated for early stage breast cancer.
  Grace Makari-Judson, Richard Viskochil, Deborah Katz, Ruth Barham, Wilson C Mertens> ;Breast Cancer Research and Treatment. 2022 Jul 1
• 105 citations
  Weight gain following breast cancer diagnosis: Implication and proposed mechanisms.
  Grace Makari-Judson, Barry Braun, D. Joseph Jerry, Wilson C. Mertens> ;World Journal of Clinical Oncology. 2014 Aug 10
• 4 citations
  Using Quality Oncology Practice Initiative Metrics for Physician Incentive Compensation
  Grace Makari-Judson, Tamara Wrenn, Wilson C. Mertens, Gordon Josephson, James A. Stewart> ;Journal of Oncology Practice. 2014 Jan 1
• Collaboration in the commonwealth.
  Suzanne Bharati Hendery, Wilson C. Mertens> ;Marketing Health Services. 2013 Jan 1
• 6 citations
  Using process elicitation and validation to understand and improve chemotherapy ordering and delivery.
  Wilson C. Mertens, Stefan C. Christov, George S. Avrunin, Lori A. Clarke, Leon J. Osterweil, Lucinda Cassells, Jenna L. Marquard> ;Joint Commission Journal on Quality and Patient Safety. 2012 Nov 1
• 7 citations
  Relapsed acute promyelocytic leukemia in a hemodialysis-dependent patient treated with arsenic trioxide: a case report
  Gregory Scott Emmons, Richard H. Steingart, James A. Stewart, Wilson C. Mertens> ;Journal of Medical Case Reports. 2012 Oct 18
• Breast cancer survivor perceptions regarding relapse and related disease risk.
  Makari-Judson G, Loke C, Katz D, Barham R, Mertens WC> ;J. Clin. Oncol.. 2011-05-20
• Recalling breast cancer presentation and therapy: Associations between patient inaccuracy and demographic characteristics.
  Mertens WC, Loke C, Katz D, Barham R, Makari-Judson G> ;J. Clin. Oncol.. 2011-05-20
• 38 citations
  Chronic diarrhea associated with persistent norovirus excretion in patients with chronic lymphocytic leukemia: report of two cases.
  Todd F. Capizzi, Grace Makari-Judson, Richard H. Steingart, Wilson C. Mertens> ;BMC Infectious Diseases. 2011 May 17
• A randomized pilot study of acupuncture for control of treatment-induced menopausal symptoms in breast cancer patients.
  Rockwell L, Makari-Judson G, Moran J, Varner J, Barham R, Mertens WC> ;J. Clin. Oncol.. 2008-05-20
• Chemotherapy ordering and delivery: Rigorously defining and analyzing a complex process employing software engineering techniques.
  Mertens WC, Christov S, Avrunin GS, Cassells LJ, Chen B, Brown DE, Parisi R, Clarke LA, Osterweil LJ> ;J. Clin. Oncol.. 2008-05-20
• 3 citations
  Formally Defining Medical Processes
  Stefan C. Christov, Bin Chen, George S. Avrunin, Lori A. Clarke, Leon J. Osterweil, David F. Brown, Lucinda Cassells, Wilson C. Mertens> ;Methods of Information in Medicine. 2008 Jan 1
• 16 citations
  Does therapeutic touch ease the discomfort or distress of patients undergoing stereotactic core breast biopsy? A randomized clinical trial.
  Leslie Smith Frank, James L. Frank, David E. March, Grace Makari-Judson, Ruth Barham, Wilson C. Mertens> ;Pain Medicine. 2007 Jul 1
• 94 citations
  Longitudinal patterns of weight gain after breast cancer diagnosis: observations beyond the first year.
  Grace Makari-Judson, Christopher H Judson, Wilson C. Mertens> ;The Breast Journal. 2007 May 1
• Chemotherapy ordering in a computerized physician order entry (CPOE) environment: A longitudinal analysis of defects from oncologist to patient.
  Mertens WC, Cassells LJ, Brown DE, Koertge V, Cabana L, Parisi R, Naglieri-Prescod D, Higby DJ> ;J. Clin. Oncol.. 2006-06-20
• 3 citations
  Can a cancer program-sponsored spiritual event meet with acceptance from patients and other attendees?
  Nancy J. Dann, Donald J. Higby, Wilson C. Mertens> ;Integrative Cancer Therapies. 2005 Sep 1
• Are oncologists effective in modifying patient-perceived breast cancer risk and associated anxiety?
  Mertens WC, Katz D, Quinlan M, Hoffman D, Carr C, Makari-Judson G> ;J. Clin. Oncol.. 2005-06-01
• 43 citations
  Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II ...
  Francis W. Nugent, Wilson C. Mertens, Stephen L. Graziano, Nathan Levitan, Rufus Collea, Ajeet Gajra, Janine Marshall, John McCann> ;Lung Cancer. 2005 May 1
• A structured spiritual service for cancer patients and families: Analysis of attendee responses.
  Dann NJ, Higby DJ, Mertens WC> ;J. Clin. Oncol.. 2004-07-15
• Is hormone-replacement therapy (HRT) a plausible explanation for the recent increase in large breast tumor incidence?
  Mertens WC, Hilbert V, Katz D, Arenas RB, Makari-Judson G> ;J. Clin. Oncol.. 2004-07-15
• 15 citations
  Contralateral breast cancer: factors associated with stage and size at presentation.
  Wilson C. Mertens, Veronica Hilbert, Grace Makari-Judson> ;The Breast Journal. 2004 Jul 1
• 3 citations
  Association of admission date with cancer patient survival at a regional hospice: utility of a statistical process control analysis.
  Wilson C. Mertens, Nancy Hoople, Carol Rodrigues, Peter K. Lindenauer, Evan M. Benjamin> ;The American Journal of Hospice & Palliative Care. 2004 Jul 1
• 5 citations
  Taking a "leap of faith": acceptance and value of a cancer program-sponsored spiritual event.
  Nancy J. Dann, Wilson C. Mertens> ;Cancer Nursing. 2004 Mar 1
• 60 citations
  Improving the Care of Patients With Regard to Chemotherapy-Induced Nausea and Emesis: The Effect of Feedback to Clinicians on Adherence to Antiemetic Prescribing Guide...
  Wilson C. Mertens, Donald J. Higby, David F. Brown, Regina Parisi, Janice Fitzgerald, Evan M. Benjamin, Peter K. Lindenauer> ;Journal of Clinical Oncology. 2003 Apr 1
• Join now to see all

Journal Articles

• The treatment of hypercalcemia.  
  Mertens, W.C, Pain Management Newsletter
• Systemic radionuclides in the treatment of symptomatic bony metastases: The clinical trial era arrives.  
  Mertens, W.C., Porter, A.T., Int Oncol Monitor

Books/Book Chapters

• Adjuvant chemotherapy for soft tissue sarcomas. 
  Chapter: New Developments in the Multidisciplinary Approach to Treatment, 
  Page 93 - 103Mertens, W.C., Bramwell, V.H.CEditors: .M. Pinedo, J., Verweij, H. Suit, Norwell, M.A.Kluwer Academic Publishers
• Recent advances in radionuclide therapy of bone metastases. 
  Chapter: Nuclear Medicine Annual, L.M 
  Page 69 - 89Mertens, W.C., Reid, R.H., Porter, A.T., Powe, J.EEditors: Freeman.New York, Raven Press
• Adjuvant chemotherapy for soft tissue sarcomas. 
  Chapter: Multidisciplinary Treatment of Soft Tissue Sarcomas 
  Page 117 - 134Mertens, W.C., Bramwell, V.H.CEditors: H.M. Pinedo, J., Verweij, H., H. Suit Norwell, M.A..Kluwer Academic Publishers
• Combination of chronic indomethacin and intermittent interleukin-2 therapy in the treatment of disseminated cancer. 
  Chapter: Combination Therapies 2 
  Page 155 - 165Lala, P.K., Al-Mutter, N., Parhar, R.S., Saarloos, M.N., Banerjee, D., Bramwell, V., Mertens, W.CEditors: A.L., Goldstein, E. Garaci.Plenum Press, New York
• Brown’s Otolaryngology, Vol. 1, Basic Sciences. 
  Chapter: Cancer Biology 
  Mertens, W.CEditors: M.Gleeson.Butterworth Heinemann, Oxford
• Chemotherapy for Soft Tissue Sarcomas. 
  Chapter: Surgery for Musculoskeletal Tumors 
  Mertens, W.C., Bramwell, V.H.CEditors: M. Simon, D. Springfield.J.B Lippincott, Philadelphia, PA
• Cancer Biology. 
  Chapter: Scott-Brown’s Otolaryngology 
  Mertens, W.CEditors: Student’s Edition, A.G. Kerr.Butterworth-Heinemann, Oxford
• Prostate Cancer. 
  Chapter: Metastatic Disease to the Musculoskeletal System. Heiner 
  Page 303 - 316Porter, A.T., Ben-Josef, E., Mertens, W.C., Ryan, J.REditors: J., Kinsella, T., Zdeblick, T.Quality Medical Publishing, St. Louis, MO
• Clinical Aspects and Management of Anal Cancer. 
  Chapter: Gastrointestinal Oncology 
  Gaspar, L.E., Mertens, W.C., Raben D., Evans, SEditors: Abbruzzese, J.L, Evans, D.B., Willett, C, Feoglio-Preiser, C.Oxford University Press, New York
• Join now to see all

Abstracts/Posters

• Neoadjuvant estramustine/etoposide followed by concurrent estramustine and definitive radiotherapy for locally-advanced prostate cancer.
  Ben-Josef., Han, S., Mertens, W., Porter, A.T., Filipczak, L., Prokop, S., Hussain, M, Proc Am Soc Clin Oncol, Presented at the Annual Meeting, American Society of Clinical Oncology, Atlanta, GA
• Contralateral breast cancer (CBC): influence of size of initial tumor and time to CBC diagnosis on CBC presentation and survival.
  Makari-Judson G., Webber, V., Mertens, W, Proc Am Soc Clin Oncol
• The changing clinical picture of contralateral breast cancer: trends for bilateral tumors since 1980, comparison with unilateral tumor stage, and the role of screening...
  Mertens, WC, Webber, V, Makari-Judson, G, Breast Cancer Treat Res, Annual San Antonio Breast Cancer Symposium, San Antonio, TX, Dec
• Radiologist-performed breast biopsies: Improving utilization of breast center resources through flexible scheduling of procedures.
  Canegallo, J, Mertens, WC, Starling, A, March, D, Makari-Judson, G, A Shewhart performance improvement cycle documented by statistical process control charting, National Consortium of Breast Centers, Las Vegas, NV
• Recent admission or death is an independent predictor of cancer patient length of survival (LOS) on a large regional Hospice program: A statistical process control (SPC).
  Mertens, WC, Hoople, NE, Rodrigues, C, Skipper, M Lindenaur, P, Benjamin, E, Proc Am Soc Clin Oncol, American Society of Clinical Oncology
• Knowledge of adverse patient outcome is the best modifier of physician practice: Compliance with chemotherapy-induced nausea/emesis (CINE) clinical practice guidelines...
  Higby DJ, Mertens, WC, Brown D, Parisi R, Fitzgerald J, Lindenaur P, Proc Am Soc Clin Oncol, American Society of Clinical Oncology
• Cancer information on the Internet: which patients are searching, or who is searching for patients.
  Al-Halawani, H, McCann, J. Mertens, WC, Proc Am Soc Clin Oncol, Annual Meeting, American Society of Clinical Oncology
• Improvement in breast cancer disease stage since 1980: women of all ages benefit.
  Mertens, WC, Hilbert V, 4th Annual Lynn Sage, Northwestern University, Chicago, IL
• The effect of therapeutic touch on patients undergoing stereotactic core breast biopsy: a randomized clinical trial.
  Frank, LS, Mertens, WC, March DE, Makari-Judson, M, Garb JL, Frank, JL, Center for Mind-Body Medicin, Comprehensive Cancer Care Symposium
• Taking a “leap of faith”: acceptance and value of a cancer-program sponsored spiritual event.
  Dann, N. J., Mertens, W.C, Proc Am Soc Clin Oncol, American Society of Clinical Oncology, Chicago, IL
• Docetaxel and COX-2 inhibition with celcoxib in relapsed/refractory non-small cell lung cancer (NSCLC): promising progression-free survival in a phase II study.
  Nugent F.W., Graziano S, Levitan, N, Collea, R., Gajra, A., Mertens, W.C., O’Connell, C., Sirard, J., Marshall, J., McCann, J, Proc Am Soc Clin Oncol
• Does therapeutic touch ease the discomfort and distress of patients undergoing stereotactic core breast biopsy.
  Frank L.S., Frank, J.L., March, D., Makari-Judson, G., Mertens, W.C, Proc Am Soc Clin Oncol
• Breast cancer patient weight gain in the adjuvant anthracycline era: defining groups at risk.
  Makari-Judson, G., Judson, C., Mertens, W.C, Proc Am Soc Clin Oncol
• Improving utilization of breast center resources through flexible scheduling of procedures.
  Mertens, W.C. Canegallo, J, WC, Starling, A, March, D, Makari-Judson, G, Proc Am Soc Clin Oncol
• Docetaxel and COX-2 inhibition with celcoxib in relapsed/refractory non-small cell lung cancer (NSCLC): promising progression-free survival in a phase II study.
  Nugent F.W., Graziano S, Levitan, N, Collea, R., Gajra, A., Mertens, W.C., O’Connell, C., Sirard, J., Marshall, J., McCann, J, oral presentation
• A structured spiritual service for cancer patients and families: analysis of attendee responses.
  Dann N.J., Higby D.J., Mertens W.C, Proc Am Soc Clin Oncol
• Is hormone replacement therapy (HRT) a plausible explanation for the recent increase in large breast tumors.
  Mertens W.C., Hilbert V, Katz D, Arenas R.B., Makari-Judson G, Proc Am Soc Clin Oncol
• A novel cancer program-sponsored spiritual event; analysis of attendee responses.
  Dann N.J., Higby D.J., Mertens, Capturing the Elusive Effect, Mayo Spiritual Care Research Conference Spirituality Measured
• Are oncologists effective in modifying patient-perceived breast cancer risk and associated anxiety.
  Mertens W.C., Katz D., Quinlan M., Hoffman D., Carr C., Makari-Judson G, Proc Am Soc Clin Oncol
• Using the Brief Symptom Inventory-18 to screen patients referred to high-breast cancer risk assessment clinic: Patient factors associated with “caseness” before and af...
  Katz, D, Makari-Judson, G, Barham, R.B., Hoffman, D., Carr, C., Quinlan, M., Mertens, W.C, San Antonio Breast Cancer Symposium
• Longitudinal patterns of weight gain after breast cancer diagnosis: observations beyond the first year.
  Makari-Judson, G., Judson, C.H., Barham, R.B., Mertens, W.C, San Antonio Breast Cancer Symposium
• Patients’ perceived breast cancer risk and psychological distress: Can oncologist-based counseling achieve durable improvements.
  Mertens, W.C., Katz, D, Quinlan, M, Barham, R.B., Hoffman, D., Carr, C., Makari-Judson, G, San Antonio Breast Cancer Symposium
• Chemotherapy ordering in a computerized physician order entry (CPOE) environment: a longitudinal analysis of defects from oncologist to patient.
  Mertens, W.C., Brown, D., Koertge, V., Cassells, L.J., Parisi, R., Naglieri-Prescod, D., Higby, D.J, Proc Am Soc Clin Oncol
• Computerized Physician Order Entry (CPOE) Employing Pre-Built Chemotherapy Regimens: Antiemetic and Supportive Care Medication Omissions.
  Cassells, L.J., Brown, D., Koertge, V., Parisi,. R., Higby, D.J., Naglieri-Prescod, D., Mertens, W.C, Annual meeting, Multinational Association for Supportive Care in Cancer
• Employing Statistical Process Control (SPC) Charting to Evaluate Menopausal Symptoms in Women Enrolled in a Clinical Trial of a Complementary Intervention.
  Rockwell, L., Makari-Judson, G., Cassells, L.J., Barham, R., Mertens, W.C, Annual meeting, Multinational Association for Supportive Care in Cancer,
• Join now to see all

Lectures

• Interleukin-2 in therapy of advanced malignancy. 
  Princess Margaret Hospital, Toronto, Ontario
• Interleukin-2 in cancer treatment. Cancer Treatment and Research Treatment. 
  Foundation of Nova Scotia, Halifax, Nova Scotia
• Management of the patient with testicular cancer. Urology Nurses of Canada 6th Annual Conference. 
  London, Canada
• Radionuclide therapy of bone metastases: Improving the therapeutic index. Advances in the treatment of metastatic prostate cancer. Symposium given at the annual mee... 
  Miami, Fl
• Aggressive Ambulatory Narcotic Management of Sickle Cell Disease-Associated Pain—barriers, impact and future. 
  Portland Health Sciences Center, Portland, OR
• Models of Failure: Lessons from Industry. 
  LENT IV Consensus Conference, St. Petersburg, FL
• Developing a Cancer Center Experience. In “The Six Ways of an Experience Producer” Presented at the Annual Meeting, Society for Healthcare Strategy and Market Developm... 
  American Hospital Association, Atlanta, GA
• Centers of Excellence Development: The Journey of a Cancer Program. Active Communications International 4th National Conference on Adding, Updating and Expanding Neuro... 
  Boston, MA
• Integrating Existing Programs into a “Center of Excellence”: Redefining Culture in a Cancer Program. World Research Group Revenue Cycle Series. 
  Building and Streamlining Neuroscience Centers of Excellence, Las Vegas, NV
• Breast and head and neck cancer: current controversies, treatments, and outcome measures. 
  American Academy of Physical Medicine and Rehabilitation, Phoenix, AZ
• Creating a Patient Experience: The D’Amour Center for Cancer Care. 
  Harvard University Graduate School of Design Review Course, Boston MA
• Integrating your existing programs into a cancer program “center of excellence”: redefining culture to create a patient experience. 
  World Research Group, Las Vegas, NV
• Re-engineering the patient experience as an instrument for competitive advantage. 
  Neuroscience Centers of Excellence, Las Vegas, NV February 28-March 2, 2005
• Re-imagining your cancer program as “great”: Pathways to a shared vision. 
  International National Conference on Developing Cancer Centers of Excellence. New York, NY
• Experience design for Centers of Excellence: Facilities and Programs. 
  Neuroscience Centers of Excellence. Las Vegas, NV February 28-March 1, 2006
• Experience Design and Patient Satisfaction. 
  Siemens Navigators’ Circle, Disney Institute, Orlando, FL
• Ambulatory Care Facilities Planning: The Evolution of the Care Practice, Technology and Design Drivers of Key Health Care Portals. 
  Harvard University Graduate School of Design, Boston, MA
• The Cancer Patient Experience: Market Competitiveness and Patient Satisfaction. 
  Optimizing Cancer Center Management Conference. Washington, DC
• Patient Experience Design: An Experience Report. 
  LEAP Forward Conference, Park City, UT
• Marketing Oncology: Service Line Strategies for Marketers. 
  HCPro Healthcare Marketplace. Webinar
• Radionuclide therapy of bone metastases: Prospects for enhancement of therapeutic efficacy. 
• Join now to see all

Other

• The importance of spiritual counseling in the care of cancer patients. 
  Mertens, W.C
  http://www.plainviews.org/AR/i/v1n15.html#1